Twitter Beğeni Hilesi

#NYValves2024 starts tomorrow! Don't miss the 1st session at Main Arena "Aortic Valve Controversies - A healthy 55 Year-Old Patient with Severe AS". Looking forward to hearing the different perspectives, debate on different options and sharing with you my 3 reasons Why I think

Don’t miss the LBCT at 11 am today #NYValves2024 to see the results of: “A randomized Comparison of TAVR vs SAVR in Low-Risk patients aged 70 Years or younger (Sub-analysis of NOTION-2 trial)”, “Predictors of BVD from the randomized SMART trial”, “Impact of Cerebral Protection

Congratulations Mahmoud Ismayl, M.D. for a great presentation #NYValves2024 ! The utilization of TAVR in patients aged 50 to 64 years in the US is increasing rapidly! Compared to SAVR, TAVR in this younger population was associated with lower complication rates and lower Inhospital

An exceptional human being! Truly inspiring. We all miss him 😔 We must follow his example and continue his work! 🙏❤️

Don’t miss “TAVR in Young Patients: Current treatment patterns in the US” today #NYValves2024 at 3:40 pm Room 402. Important topic, we will discuss TAVR utilization and short term outcomes in patients aged 50 to 54 years. See you there 🙂

Simply excellent! What a wonderful meeting! Superb content, amazing city and a great opportunity to connect with colleagues!!! I can’t wait to #NYValves2025 ! ❤️ Thank you Cardiovascular Research Foundation team for this opportunity! 🙏

The Ultimate TAVR experience!!! All Women TAVR + All from Diverse Backgrounds! From right to left: Female patient + Graduating Female SHD Interventional Fellow + Female Cardiac Surgeon who recently joined our practice + Me extremely happy🥰+ Female 3rd Year Med Student who wants

After a long day of work… Why not spend an evening together having fun with a Zumba class? We deserve some bonding time, and we get to burn few calories at the same time!😃. Thank you Mayo Clinic CV leadership for supporting Women In Cardiology! 🙏And a big thank you to my female

Looking forward to working with our new cardiology fellows. Welcome to the Mayo Clinic family!!!🙏❤️

Important findings. Sadly, not surprising. We know how to do these procedures, we now need to learn how to help reduce utilization disparities.

Excellent work by Abdullah Al-Abcha ! Extremely important findings. With incremental all-cause mortality in MAC patients according to extra-mitral cardiac damage stages, I think we should refer symptomatic patients with mitral valve dysfunction and MAC for mitral intervention

We enrolled Intermediate surgical risk patient in the Mitral Valve-in-Valve Registry of PARTNER 3 trial. A total fo 50 patients were treated with TS MViV using the Sapien 3 THV, mean age 70 years, 54% female and mean STS-PROM of 4.1%. Technical success was 98%. The 26 mm S3 and

Hot off the press! Our latest study in @Circulation reports 1-year outcomes for transseptal Mitral Valve-in-Valve, featuring the largest dataset to date! With the recent approval for intermediate risk, discover the impressive results of transseptal mitral VIV in patients with

An important highlight of SOLACI 2024. Fantastic meeting of Women As One and #WIN and MIL! Thank you SOLACI-SOCIME 2022 !!! And can’t wait to see this amazing group at our next meetings including SOLACI 2025 in Mexico 🇲🇽!

I’m so proud of our superstar fellow Mahmoud Ismayl, M.D. ! Congratulations on this important work! There is so much work to do to narrow the gap of healthcare disparities and improve the utilization of Tricuspid interventions in women, Black and Latino patients in the US.

Excellent multidisciplinary Heart Team discussion #EchoNY with Mayo Clinic CV and Columbia team RTHahnMD and Omar Khalique about Transcatheter vs Surgical interventions for VHD. A highly recommended meeting, don’t miss this meeting in NYC next year! Thank you for the invitation! 🙏

Our superstar fellow @mahmoud_ismayl presenting @ESCardio presenting “TAVR vs SAVR in patients younger than 65 years: Analysis from the National Inpatient Sample Database”. TAVR is increasingly performed among patients aged 50-64 years and is associated with lower in-hospital